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Ethnic Differences in the Prevalence of Inherited Thrombophilic
Polymorphisms in an Asymptomatic Australian Prenatal
Population
JOANNE M. SAID,1 SHAUN P. BRENNECKE,2 ERIC K. MOSES,3 SUSAN P. WALKER,4
ANTHONY J. BORG,3 JEFF T. WILLIAMS,5 AND JOHN R. HIGGINS6
Abstract Differences in the prevalence of thrombophilias in different
ethnic populations have been demonstrated. Because the Australian popula-
tion includes many different ethnic groups, we sought to assess the effect of
ethnicity in our Australian prenatal population on the prevalence of throm-
bophilic polymorphisms. Asymptomatic, nulliparous women (n 1,129) re-
cruited for a large prospective study were included in this analysis. These
women had no personal or family history of venous thromboembolism and
were not known to be carrying an inherited or acquired thrombophilia. Eth-
nicity was determined at recruitment, and women were categorized as being
of Northern European, Southern European, Middle Eastern, Asian, or Other
ethnicity. These women underwent genotyping for the following polymor-
phisms: factor V Leiden G1691A, prothrombin gene A20210G mutation,
methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C, and
thrombomodulin C1418T. The factor V Leiden allele was seen significantly
more frequently in patients of Middle Eastern background compared to those
of Northern European and Asian ethnicity ( p 0.05). The prothrombin gene
mutation was seen significantly more frequently in patients of Southern Eu-
ropean ethnicity compared to those of Northern European or Asian ethnicity
( p 0.05). The MTHFR C677T allele (mutant) was significantly less com-
mon in those of Asian ethnicity compared to patients of Northern European
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and Southern European ethnicity ( p 0.0005). There were no significant
differences seen with the MTHFR A1298C polymorphism. The mutant
thrombomodulin allele was seen significantly more frequently in Asian
women compared to Northern European, Southern European, or Middle
Eastern women ( p 0.005). There are important ethnic differences in the
prevalence of thrombophilic polymorphisms in the Australian prenatal popu-
lation.
Australia is a melting pot of diverse ethnicities. As a relatively new country,
Australia has a history of different migration patterns, ranging from the early
days of Anglo-Celtic colonization to the more recent patterns of Southern Euro-
pean, Southeast Asian, African, and Middle Eastern migration. Several studies
have already demonstrated significant differences in the prevalence of a number
of genetic thrombophilias (Rees et al. 1995; Herrmann et al. 1997; Gudnason et
al. 1998; Rosendaal et al. 1998), but there are limited data for the Australian
population.
Inherited thrombophilias predispose carriers to venous thromboembolism
(Gerhardt et al. 2000), yet most of the carriers remain asymptomatic. Recent
associations between thrombophilias and adverse pregnancy outcomes (Alfirevic
et al. 2002; Rey et al. 2003; Said and Dekker 2003) have prompted calls for
screening and institution of anticoagulant therapy in high-risk populations (Bates
et al. 2004). To fully consider the merits of such propositions, we need a more
detailed assessment of the prevalence of these conditions in prenatal populations.
Furthermore, not all studies have confirmed an association between adverse preg-
nancy outcomes and inherited thrombophilias (Livingston et al. 2001; Infante-
Rivard et al. 2002). It is possible that differences in the prevalence of inherited
thrombophilias in different ethnic groups may contribute to apparent contradic-
tions between studies.
We sought to assess the effect of ethnicity on the prevalence of five com-
mon thrombophilic polymorphisms in our Australian prenatal population: factor
V Leiden polymorphism, which has been well described as the most common
thrombophilia predisposing carriers to venous thrombosis in Caucasian popula-
tions (Dahlback 1997); the prothrombin gene mutation A20210G, which is asso-
ciated with elevated circulating prothrombin levels (Poort et al. 1996); two
polymorphisms (C677T and A1298C) in the methylenetetrahydrofolate reductase
gene (MTHFR), which contribute to the development of hyperhomocysteinemia
(Frosst et al. 1995; van der Put et al. 1998); and a common polymorphism in the
thrombomodulin gene (C1418T), which interferes with thrombin binding on the
endothelial surface and results in impaired activation of the naturally occurring
anticoagulant protein C (Dittman and Majeurs 1990).
Methods
Nulliparous women were recruited for this study from the prenatal clinics at
the Royal Women’s Hospital and the Mercy Hospital for Women, in Melbourne,
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Australia, as part of a study designed to assess the overall prevalence of throm-
bophilias in asymptomatic women and evaluate the risk of adverse pregnancy
outcomes in thrombophilic women. Patients were recruited before they reached
22 weeks’ gestation, and written consent for participation in the study was ob-
tained. Ethnicity was determined at the time of recruitment by asking a series of
questions about the patient’s ethnicity as well as that of their parents, grand-
parents, and ancestors. This project was approved by the Institutional Ethics
Committees at both hospitals. To obtain a truly asymptomatic population, which
would not otherwise be suspected of carrying a thrombophilia, women were ex-
cluded from recruitment if they were known to be carrying a thrombophilia, had
a family history of thrombophilia, had a past history or family history of venous
thromboembolism, or had more than two previous miscarriages or a previous
midtrimester miscarriage.
Because of the detailed nature of the consent process required, it was not
possible to recruit non-English-speaking women.
Venous blood was obtained from the participants in vials containing EDTA,
and a buffy coat layer was prepared from whole blood. Genomic DNA was then
extracted from peripheral blood leukocytes using a commercially available kit
(Puregene Whole Blood Kit, Gentra Systems, Minneapolis, Minnesota). Geno-
typing for the five polymorphisms was performed using Taqman assays in an ABI
Prism 7700 Sequencer, using primers and fluorescent MGB probes designed
using Primer Express Software and validated in the Pregnancy Research Centre
at the Royal Women’s Hospital. (Primer and probe sequences are given in Table
1.) Each PCR reaction was performed in a 10-l volume using 2 l genomic
DNA (concentration 10 ng/l), 5 l Thermo-Start Q-PCR MasterMix (ABgene,
Applied Biosystems, Foster City, California), 0.09 l of the forward and reverse
primers, 0.02 l FAM and VIC labeled fluorescent probes, 0.03 l Rox, and 2.75
l H2O, with the following PCR thermocycler conditions: initial activation step
at 95C followed by PCR amplification of 40 cycles (denaturation at 95C for 15
s, primer annealing at 62C, extension at 72C for 30 s) and a final extension step
at 72C for 5 min. Fluorescence detection of PCR products was carried out in the
7700 Sequence Detector according to the manufacturer’s recommendations.
Statistical Analysis. The prevalence and 95% confidence interval of each
polymorphism was derived using Stata 7.0.
Differences between the prevalence in each ethnic subgroup were analyzed
using the two-sample test of proportion for independent proportions. A p value
less than 0.05 was regarded as significant, indicating that the difference in preva-
lence between the two ethnic groups was significant.
Results
This study included 1,129 women of known ethnicity. These women had
all five polymorphisms successfully genotyped.
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Table 1. Primer and Probe Sequences
Polymorphism Sequence
Factor V Leiden
Forward primer AGACATCGCCTCTGGGCTAA
Reverse primer CTGAAAGGTTACTTCAAGGACAAAATAC
FAM probe (wild type) 6FAM-TATTCCTCGCCTGTCC-MGBNFQ
VIC probe (factor V Leiden) VIC-TGTATTCCTTGCCTGTC-MGBNFQ
Prothrombin gene mutation
Forward primer AACCAATCCCGTGAAAGAATTATTT
Reverse primer CCAGAGAGCTGCCCATGAAT
FAM probe (wild type) 6FAM-TTGAGGCTCGCTGAG-MGBNFQ
VIC probe (prothrombin) VIC-TTGAGGCTTGCTGAGA-MGBNFQ
MTHFR C677T
Forward primer TGGCAGGTTACCCCAAAGG
Reverse primer CACAAAGCGGAAGAATGTGTCA
FAM probe (C allele) 6FAM-AAATCGGCTCCCGCA-MGBNFQ
VIC probe (T allele) VIC-ATGATGAAATCGACTCC-MGBNFQ
MTHFR A1298C
Forward primer AAGAGCAAGTCCCCCAAGGA
Reverse primer ACTTTGTGACCATTCCGGTTTG
FAM probe (A allele) 6FAMAAGACACTTTCTTCACTGMGBNFQ
VIC probe (C allele) VIC-AAGACACTTGCTTCAC-MGBNFQ
Thrombomodulin
Forward primer CCTCCCCGGTACCTTCGA
Reverse primer TCCACCTTGCCGGAGTCA
FAM probe (wild type) 6FAM-CCCTTGCCCGCCAC-MGBNFQ
VIC probe (mutant allele) VIC-CCCTTGTCCGCCACA-MGBNFQ
Most of the women were of Northern European descent (64%). Southern
European and Asian women represented 15% and 13% of the population, respec-
tively, and 6% of the women were from Middle Eastern countries (Lebanon,
Israel, and Turkey predominantly). A further 2% of women (25 women) had
other ethnic backgrounds, including African (n 15) and Australian Aboriginal
(n 1), or were of mixed ethnicity (n 9). Because this last group represented
an extremely heterogeneous group and because the numbers in each individual
group were too small to provide meaningful results, they were excluded from
further analysis, leaving 1,104 women in this study.
The allele frequency of the mutant genes in each ethnic subgroup is shown
in Table 2.
Factor V Leiden. We identified 60 women as heterozygous carriers of factor
V Leiden. No women were homozygous for this mutation. The allele frequency
for each ethnic group is shown in Table 2. The factor V Leiden mutation was least
common in patients of Asian background compared to all other ethnic groups (p
 0.05). Middle Eastern women were more likely to carry this mutation than
PAGE 406................. 16219$ $CH2 11-03-06 13:56:43 PS
Inherited Thrombophilic Polymorphisms / 407
Ta
bl
e
2.
Fr
eq
ue
nc
y
o
fM
u
ta
nt
A
lle
le
si
n
D
iff
er
en
tE
th
ni
c
G
ro
up
s
Al
le
le
No
rt
he
rn
Eu
ro
pe
an
(n

73
2)
N
um
be
r
o
fM
ut
an
t
Al
le
le
s
Pr
ev
al
en
ce
(95
%
CI
)
So
ut
he
rn
Eu
ro
pe
an
(n

16
5)
N
um
be
r
o
fM
ut
an
t
Al
le
le
s
Pr
ev
al
en
ce
(95
%
CI
)
As
ia
n
(n

14
3)
N
um
be
r
o
fM
ut
an
t
Al
le
le
s
Pr
ev
al
en
ce
(95
%
CI
)
M
id
dl
e
Ea
st
er
n
(n

64
)
N
um
be
r
o
fM
ut
an
t
Al
le
le
s
Pr
ev
al
en
ce
(95
%
CI
)
Si
gn
ific
an
ce
o
f
Co
m
pa
ris
on
Be
tw
ee
n
Tw
o
Et
hn
ic
G
ro
up
sa
Fa
ct
or
V
Le
id
en
42
2.
86
%
(2.
07
–3
.8
5)
9
2.
73
%
(1.
25
–
5.
11
)
1
0.
35
%
(0
–
1.
93
)
8
6.
25
%
(2.
74
–
11
.9
4)
N
E:
SE
,p

0.
89
N
E:
A
,p

0.
01
b
N
E:
M
E,
p

0.
04
b
SE
:A
,p

0.
02
b
SE
:M
E,
p

0.
07
A
:M
E,
p

0.
00
01
b
Pr
ot
hr
om
bi
n
ge
ne
m
u
ta
tio
n
14
0.
96
%
(0.
52
–
1.
60
)
8
2.
42
%
(1.
05
–
4.
72
)
1
0.
35
%
(0
–
1.
93
)
2
1.
56
%
(0.
29
–
5.
53
)
N
E:
SE
,p

0.
01
b
N
E:
A
,p

0.
31
N
E:
M
E,
p

0.
51
SE
:A
,p

0.
02
b
SE
:M
E,
p

0.
47
A
:M
E,
p

0.
18
M
TH
FR
C6
77
T
50
3
34
.3
6%
(31
.92
–
36
.8
5)
12
9
39
.0
9%
(33
.79
–
44
.5
8)
61
21
.3
2%
(16
.73
–
26
.5
4)
42
32
.8
1%
(24
.78
–
41
.6
7)
N
E:
SE
,p

0.
10
N
E:
A
,p

0.
00
01
b
N
E:
M
E,
p

0.
72
SE
:A
,p

0.
00
01
b
SE
:M
E,
p

0.
21
A
:M
E,
p

0.
01
b
PAGE 407................. 16219$ $CH2 11-03-06 13:56:44 PS
408 / said et al.
Ta
bl
e
2.
(C
on
tin
ue
d)
Al
le
le
No
rt
he
rn
Eu
ro
pe
an
(n

73
2)
N
um
be
r
o
fM
ut
an
t
Al
le
le
s
Pr
ev
al
en
ce
(95
%
CI
)
So
ut
he
rn
Eu
ro
pe
an
(n

16
5)
N
um
be
r
o
fM
ut
an
t
Al
le
le
s
Pr
ev
al
en
ce
(95
%
CI
)
As
ia
n
(n

14
3)
N
um
be
r
o
fM
ut
an
t
Al
le
le
s
Pr
ev
al
en
ce
(95
%
CI
)
M
id
dl
e
Ea
st
er
n
(n

64
)
N
um
be
r
o
fM
ut
an
t
Al
le
le
s
Pr
ev
al
en
ce
(95
%
CI
)
Si
gn
ific
an
ce
o
f
Co
m
pa
ris
on
Be
tw
ee
n
Tw
o
Et
hn
ic
G
ro
up
sa
M
TH
FR
A
12
98
C
44
3
30
.2
6%
(27
.91
–3
2.
68
)
10
5
31
.8
1%
(26
.82
–
37
.1
4)
78
27
.2
7%
(22
.19
–
32
.8
2)
47
36
.7
1%
(28
.38
–
45
.6
9)
N
E:
SE
,p

0.
58
N
E:
A
,p

0.
31
N
E:
M
E,
p

0.
13
SE
:A
,p

0.
22
SE
:M
E,
p

0.
32
A
:M
E,
p

0.
05
Th
ro
m
bo
m
od
ul
in
po
ly
m
or
ph
ism
27
5
18
.7
8%
(16
.81
–2
0.
88
)
40
12
.1
2%
(8.
80
–
16
.1
3%
)
76
26
.5
7%
(21
.54
–
32
.0
9)
8
6.
25
%
(2.
74
–
11
.9
4)
N
E:
SE
,p

0.
00
4b
N
E:
A
,p

0.
00
3b
N
E:
M
E,
p

0.
00
05
b
SE
:A
,p

0.
00
01
b
SE
:M
E,
p

0.
07
A
:M
E,
p

0.
00
01
b
a.
N
E,
N
o
rt
he
rn
Eu
ro
pe
an
;S
E,
So
ut
he
rn
Eu
ro
pe
an
;A
,A
sia
n;
M
E,
M
id
dl
e
Ea
st
er
n.
b.
Si
gn
ifi
ca
nt
fre
qu
en
cy
o
ft
he
m
u
ta
nt
al
le
le
be
tw
ee
n
th
e
tw
o
et
hn
ic
gr
ou
ps
in
di
ca
te
d.
PAGE 408................. 16219$ $CH2 11-03-06 13:56:44 PS
Inherited Thrombophilic Polymorphisms / 409
Northern European women ( p 0.05) or Asian women ( p 0.0005). No sig-
nificant differences were seen between Northern and Southern European women.
Prothrombin Gene Mutation. Twenty-five of the 1,104 women were hetero-
zygous carriers of the prothrombin gene mutation. This mutant allele was sig-
nificantly more common in Southern European women than in Northern
European or Asian women ( p 0.05). No statistically significant differences
were observed in the frequency of the mutant allele in the Middle Eastern popula-
tion compared to any other ethnic groups.
MTHFR C677T. One hundred thirty-one women were homozygous for the
MTHFR C677T polymorphism, which is associated with hyperhomocysteinemia.
The mutant allele was seen significantly less frequently in Asian women com-
pared to Northern European and Southern European women ( p 0.0001) and
Middle Eastern women ( p 0.05).
MTHFR A1298C. Homozygosity for the MTHFR A1298C polymorphism
was seen in 111 women, and 451 women were heterozygous for this polymor-
phism. No statistically significant differences were seen among any of the ethnic
groups.
Significant linkage disequilibrium was observed between the two MTHFR
loci within each ethnic subgroup.
Thrombomodulin Polymorphism. Thirty-eight women were homozygous
for the thrombomodulin polymorphism. The mutant allele was significantly more
common in Asian women than in all other ethnic groups ( p 0.005). In addition,
significant differences in the frequency of the mutant allele were also seen be-
tween Northern and Southern European women and between Northern European
and Middle Eastern women ( p 0.005).
All five polymorphisms were in Hardy-Weinberg equilibrium within each
ethnic subgroup.
Discussion
These data confirm the findings of previous studies, which have suggested
a high prevalence of the factor V Leiden mutation in Middle Eastern subjects
(Awidi et al. 1999; Irani-Hakime et al. 2000) and a virtual absence of this poly-
morphism in Asian populations (Rees et al. 1995; Angchaisuksiri et al. 2000).
The prevalence of this polymorphism in our Northern European population is
similar to that seen in other Caucasian populations (Lee et al. 1996; Ridker et al.
1997; Livingstone et al. 2000). These differences in the prevalence support the
theory that the Factor V Leiden mutation arose in a single common ancestor
21,000 to 34,000 years ago (after the separation of Africans and Asians from
Caucasian populations) (Zivelin et al. 1997).
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Likewise, the prothrombin gene mutation is rarely seen in Asian popula-
tions (Angchaisuksiri et al. 2000; Chan et al. 2000) but is slightly more prevalent
in Southern European populations than in Northern European populations (Ro-
sendaal et al. 1998).
The MTHFR C677T polymorphism is more prevalent in Caucasian popula-
tions than in Asian (Esfahani et al. 2003) or African populations (Conroy et al.
2000; Esfahani et al. 2003). In contrast to the findings of Esfahani et al. (2003),
we did not find any significant differences in the prevalence of the MTHFR
A1298C polymorphism among the different ethnic groups. Significant linkage
disequilibrium was observed between the two MTHFR loci among all four ethnic
groups. This finding is consistent with the previous study by van der Put et al.
(1998) but contrasts with the findings of Isotalo et al. (2000), who described the
presence of triple and quadruple mutations in fetal samples, which could arise
only if linkage disequilibrium were incomplete.
The significantly higher prevalence of the thrombomodulin polymorphism
in Asian women is an important finding and requires further investigation of the
possible role of this polymorphism in contributing to both venous thromboembo-
lism and adverse pregnancy outcomes in these populations. To our knowledge,
this is the largest population in whom the prevalence of this polymorphism has
been examined.
We aimed to assess the prevalence of these thrombophilic polymorphisms
in a population that would not otherwise be suspected of carrying thrombophilias.
As such, we excluded women who had a personal or family history of thrombo-
embolism, women who were known to carry or to have a family history of throm-
bophilia, and women who had had more than two previous miscarriages or a
previous midtrimester miscarriage. There is no doubt that, according to these
strict criteria, we will be underestimating the true population prevalence of
thrombophilia—this is better achieved using random population-based samples
(Gibson et al. 2005). Nevertheless, we have demonstrated that inherited throm-
bophilias are indeed prevalent in an asymptomatic prenatal population.
As illustrated in Table 2, we performed 30 separate statistical analyses. We
acknowledge that this type of multiple analysis may result in the detection of a
statistical difference simply by chance alone. Using a Bonferroni adjustment,
statistical comparisons resulting in p 0.0017 would still be regarded as signifi-
cant. Table 2 highlights a number of highly significant differences in the preva-
lence of thrombophilias between ethnic groups. Significance for a number of
these analyses is retained even when the Bonferroni adjustment is applied.
The prevalence of a particular thrombophilia will have a direct effect on
the sample size required to study the association between inherited thrombophi-
lias and adverse pregnancy outcomes. As this study and previous studies have
demonstrated, the prevalence of thrombophilias varies significantly among differ-
ent ethnic groups. These differences may contribute to the apparent contradic-
tions seen in studies that examine the relationship between thrombophilias and
adverse pregnancy outcomes.
PAGE 410................. 16219$ $CH2 11-03-06 13:56:45 PS
Inherited Thrombophilic Polymorphisms / 411
Acknowledgments We gratefully acknowledge the work of the clinical research mid-
wives, pathology collection staff, and laboratory specimen handlers at both the Mercy
Hospital for Women and the Royal Women’s Hospital for their invaluable assistance in
the recruitment of subjects and sample collection. This project was supported by grants
from the Kings Jubilee Fund (City of Melbourne), the Royal Women’s Hospital, and the
University of Melbourne (Australian Postgraduate Award and Felix Meyer Scholarship).
Received 19 December 2005; revision received 8 June 2006.
Literature Cited
Alfirevic, Z., D. Roberts, and V. Martlew. 2002. How strong is the association between maternal
thrombophilia and adverse pregnancy outcome? A systematic review. Eur. J. Obstet. Gynecol.
Reprod. Biol. 101(1):6–14.
Angchaisuksiri, P., S. Pingsuthiwong, K. Aryuchai et al. 2000. Prevalence of the G16191A mutation
in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the
Thai population. Am. J. Hematol. 65(2):119–122.
Awidi, A., M. Shannak, A. Bseiso et al. 1999. High prevalence of factor V Leiden in healthy Jorda-
nian Arabs. Thromb. Haemost. 81:582–584.
Bates, S., I. Greer, J. Hirsh et al. 2004. Use of antithrombotic agents during pregnancy: The Seventh
ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3):627S–644S.
Chan, D. K., G. Hu, H. Tao et al. 2000. A comparison of polymorphism in the 3-untranslated region
of the prothrombin gene between Chinese and Caucasians in Australia. Br. J. Haematol.
111:1253–1255.
Conroy, J. M., G. Trivedi, T. Sovd et al. 2000. The allele frequency of mutations in four genes that
confer enhanced susceptibility to venous thromboembolism in an unselected group of New
York state newborns. Thromb. Res. 99:317–324.
Dahlback, B. 1997. Resistance to activated protein C due to factor V R506Q mutation as a cause of
venous thrombosis. Rev. Invest. Clin. 49(suppl. 1):3–5.
Dittman, W. A., and P. W. Majeurs. 1990. Structure and function of thrombomodulin: A natural
anticoagulant. Blood 75(2):329–336.
Esfahani, S. T., E. A. Cogger, and M. A. Caudill. 2003. Heterogeneity in the prevalence of methylene-
tetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J. Am.
Diet. Assoc. 103(2):200–207.
Frosst, P., H. J. Blom, and R. Milos et al. 1995. A candidate genetic risk factor for vascular disease:
A common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:111–113.
Gerhardt, A., R. E. Scharf, M. W. Beckmann et al. 2000. Prothrombin and factor V mutations in
women with a history of thrombosis during pregnancy and the puerperium. New Engl. J. Med.
342(6):374–380.
Gibson, C. S., A. H. MacLennan, Z. Rudzki et al. 2005. The prevalence of inherited thrombophilias
in a Caucasian Australian population. Pathology 37(2):160–163.
Gudnason, V., D. Stansbie, J. Scott et al. 1998. C677T (thermolabile alanine/valine) polymorphism
in methylenetetrahydrofolate reductase (MTHFR): Its frequency and impact on plasma homo-
cysteine concentration in different European populations. Atherosclerosis 136:347–354.
Herrmann, F. H., M. Koesling, W. Schroder et al. 1997. Prevalence of factor V Leiden mutation in
various populations. Genet. Epidemiol. 14:403–411.
Infante-Rivard, C., G.-E. Rivard, W. V. Yotov et al. 2002. Absence of association of thrombophilia
polymorphisms with intrauterine growth restriction. New Engl. J. Med. 347(1):19–25.
PAGE 411................. 16219$ $CH2 11-03-06 13:56:46 PS
412 / said et al.
Irani-Hakime, N., H. Tamim, R. Kreidy et al. 2000. The prevalence of factor V R506Q mutation-
Leiden among apparently healthy Lebanese. Am. J. Hematol. 65:45–49.
Isotalo, P. A., G. A. Wells, and J. G. Donnelly. 2000. Neonatal and fetal methylenetetrahydrofolate
reductase genetic polymorphisms: An examination of C677T and A1298C mutations. Am. J.
Hum. Genet. 67:986–990.
Lee, D. H., P. A. Henderson, and M. A. Blajchman. 1996. Prevalence of factor V Leiden in a Cana-
dian blood donor population. Can. Med. Assoc. J. 155(3):296–298.
Livingston, J. C., J. R. Barton, V. Park et al. 2001. Maternal and fetal inherited thrombophilias are not
related to the development of severe preeclampsia. Am. J. Obstet. Gynecol. 185(1):153–157.
Livingstone, W. J., C. Keenan, B. White et al. 2000. Prevalence of the factor V R506Q mutation in
two Irish control populations: Use of a novel nested polymerase chain reaction approach. Br.
J. Haematol. 111:559–561.
Poort, S. R., F. R. Rosendaal, P. H. Reitsma et al. 1996. A common genetic variation in the 3-
untranslated region of the prothrombin gene is associated with elevated plasma prothrombin
levels and an increase in venous thrombosis. Blood 88(10):3698–3703.
Rees, D. C., M. Cox, and J. B. Clegg. 1995. World distribution of factor V Leiden. Lancet 346:1133–
1134.
Rey, E., S. R. Kahn, M. David et al. 2003. Thrombophilic disorders and fetal loss: A meta-analysis.
Lancet 361(9361):901–908.
Ridker, P. M., J. P. Miletich, C. H. Hennekens et al. 1997. Ethnic distribution of factor V Leiden in
4,047 men and women: Implications for venous thromboembolism screening. J. Am. Med.
Assoc. 277(16):1305–1307.
Rosendaal, F. R., C. J. M. Doggen, A. Zivelin et al. 1998. Geographic distribution of the 20210 G to
A prothrombin variant. Thromb. Haemost. 79:706–708.
Said, J., and G. Dekker. 2003. Pre-eclampsia and thrombophilia. Best Pract. Res. Clin. Obstet. Gyn-
aecol. 17(3):441–458.
van der Put, N. M. J., F. Gabreels, E. M. B. Stevens et al. 1998. A second common mutation in the
methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects?
Am. J. Hum. Genet. 62:1044–1051.
Zivelin, A., J. H. Griffin, X. Xu et al. 1997. A single genetic origin for a common Caucasian risk
factor for venous thrombosis. Blood 89(2):397–402.
PAGE 412................. 16219$ $CH2 11-03-06 13:56:46 PS
